No Data
No Data
Liquidia Draws Bullish View at Raymond James on Yutrepia Potential
Insider Sale: Director Raymond Dwek Sells 5,000 Shares of United Therapeutics Corp (UTHR)
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
H.C. Wainwright Maintains United Therapeutics(UTHR.US) With Buy Rating, Maintains Target Price $400
Express News | United Therapeutics Corp : UBS Cuts Target Price to $365 From $370
Morgan Stanley Downgrades United Therapeutics(UTHR.US) to Hold Rating, Raises Target Price to $337
No Data